Adagio Medical Holdings, Inc.
ADGM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | – | – | 100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | 309.1% |
| R&D Expenses | $3 | $2 | $4 | $3 |
| G&A Expenses | $0 | $0 | $0 | $1 |
| SG&A Expenses | $3 | $0 | $0 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2 |
| Other Operating Expenses | $0 | $2 | $3 | $45 |
| Operating Expenses | $6 | $4 | $7 | $50 |
| Operating Income | -$6 | -$5 | -$7 | -$51 |
| % Margin | – | – | – | 35,513.5% |
| Other Income/Exp. Net | -$4 | $1 | -$0 | $3 |
| Pre-Tax Income | -$10 | -$4 | -$8 | -$48 |
| Tax Expense | $0 | $0 | $0 | $9 |
| Net Income | -$10 | -$4 | -$8 | -$53 |
| % Margin | – | – | – | 36,925.4% |
| EPS | -0.66 | -0.26 | -0.5 | -3.55 |
| % Growth | -153.8% | 48% | 85.9% | – |
| EPS Diluted | -0.66 | -0.35 | -0.5 | -3.55 |
| Weighted Avg Shares Out | 15 | 15 | 15 | 15 |
| Weighted Avg Shares Out Dil | 15 | 15 | 15 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $1 | $1 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$9 | -$4 | -$7 | -$56 |
| % Margin | – | – | – | 39,353.1% |